Find a Clinical Trial
Filter
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
GO MOMS
Pregnancy
All genders
18+
Recruiting now
Department of Obstetrics + Gynecology
IPASS
Intracranial pressure
All genders
6+
Recruiting now
Department of Neurology
Infant Vision Health and Prenatal Drug Exposure
Vision health
All genders
0-5
Recruiting now
Department of Obstetrics + Gynecology